8
Participants
Start Date
May 23, 2022
Primary Completion Date
March 25, 2025
Study Completion Date
March 25, 2025
Cenegermin Ophthalmic Solution [Oxervate]
An 8-week course of topical cenegermin eye drops given 6 times daily would be started in the affected eye, in conjunction with the pre-existing medical treatment for neurotrophic keratopathy. Patients will be followed-up at 4 weeks, 6 weeks, 8 weeks, 3 months, 6 months, 9 months and 12 months (±2 weeks at each time point) after treatment. At each visit, patients will be assessed to determine the corneal epithelial defect and corneal sensation.
University of California, Los Angeles, Los Angeles
Dompé Farmaceutici S.p.A
INDUSTRY
University of California, Los Angeles
OTHER